Skip to content

Accu O2 Oxygen Analyzer

by Precision Medical Inc

510(k) K173807

Accu O2 Oxygen Analyzer is a medical device (FDA Class II; FDA product code CCL, Analyzer, Gas, Oxygen, Gaseous-Phase) made by Precision Medical Inc, cleared under FDA 510(k) K173807 on 2 May 2018, active as of 8 Nov 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Abbreviated NumberK173807 Date2 May 2018ClearedStatusActive

Official records

From the FDA record

Received by the FDA
15 Dec 2017
FDA decision
2 May 2018 (Substantially Equivalent)
FDA review time
138 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K173807 (openFDA), as read on 8 Nov 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
CCL
FDA applicant
Precision Medical, Inc.
Device class
Class II
Regulation
21 CFR Part 868.1720
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Devices cleared under K173807

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K173807
UDI-DISize and differences
Precision Medical Inc. PM5950
Precision Medical Inc
PM5950 / PM595000855887006870 —On the market

Similar devices

Other devices filed under FDA product code CCL (Analyzer, Gas, Oxygen, Gaseous-Phase).

Other devices from Precision Medical Inc

See all devices from Precision Medical Inc →